E. Zuffi

Immunoreactivity against linear epitopes of parvovirus B19 structural proteins. Immunodominance of the amino‐terminal half of the unique region of VP1

M. Zerbini, S. Venturoli, G. Gallinella, 2000, Journal of medical virology.

Expression of firefly luciferase gene in Erwinia amylovora.

S. Girotti, S. Ghini, M. Zerbini, 2003, Luminescence : the journal of biological and chemical luminescence.

Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans.

M. Zerbini, G. Gentilomi, S. Venturoli, 2001, Viral immunology.

Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19‐correlated diseases

F. Bonvicini, M. Zerbini, M. Cricca, 2003, Journal of medical virology.

Analysis of B19 virus contamination in plasma pools for manufacturing, by using a competitive polymerase chain reaction assay

F. Bonvicini, M. Zerbini, G. Gallinella, 2002, Vox sanguinis.

Different patterns of restriction to B19 parvovirus replication in human blast cell lines.

L. Bonsi, M. Zerbini, S. Venturoli, 2000, Virology.

Diagnosis and quantitative evaluation of parvovirus B19 infections by real‐time PCR in the clinical laboratory

Francesca Bonvicini, Monica Musiani, F. Bonvicini, 2002, Journal of medical virology.

Humoral immune response to parvovirus B19 and serological diagnosis of B19 infection.

F. Bonvicini, M. Zerbini, M. Cricca, 2002, Clinical laboratory.

Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins

M. Zerbini, G. Gentilomi, G. Gallinella, 2001, Journal of medical virology.